Review Paper | 2026 | Volume 2 | Issue 1 | Page 15-24 1. Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE 2. Dr. Rabia Fatima, Lecturer, Cardiology, DMCH-UAE Abstract Background: For decades, tricuspid regurgitation (TR) was relegated to the status of the "forgotten valve," often managed conservatively until the onset of irreversible right heart failure. However, the 2024–2026 clinical landscape has been redefined by the success of Transcatheter Tricuspid Edge-to-Edge Repa

Original Research | 2026 | Volume 2 | Issue 1 | Page 01-14 Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE Abstract For decades, dual antiplatelet therapy (DAPT)—combining aspirin with a P2Y_{12} inhibitor—has been the gold standard for preventing thrombotic complications following percutaneous coronary intervention (PCI). However, the advent of third-generation drug-eluting stents (DES) with thinner struts and biocompatible polymers has significantly reduced stent thromb

Original Research | 2026 | Volume 2 | Issue 1 | Page 25-33 Dr. Amin Sekha Hassain, Professor, Cardiology, Dubai Medical College, UAE Abstract The management of Chronic Heart Failure (CHF) is currently transitioning from intermittent, clinic-based snapshots to a model of Continuous Physiological Surveillance . In the 2024–2026 digital health landscape, the proliferation of consumer-grade and medical-grade wearables (smartwatches, rings, and patches) has created a vast reservoi

Review Paper | 2026 | Volume 2 | Issue 1 | Page 84-88 Dr. Abhimita Singh, Professor, Cardiology, JMCH, Jalgwao, MP Abstract While mechanical and robotic innovations have redefined the physical landscape of the catheterization lab, the success of these procedures remains inextricably linked to advanced Pharmacotherapy. The "NextGen" era of intervention is not just about the hardware of stents and valves, but the biological management of the blood-surface interface. This chapte

Review Paper | 2026 | Volume 2 | Issue 1 | Page 78 - 83 Dr. Amali Singh Tanuja, Assistant Professor, Department of Cardiology, GMC, Sis UP Abstract The clinical landscape of interventional cardiology is increasingly defined by the CHIP (Complex High-Risk Indicated Patient) population—a cohort characterized by complex coronary anatomy, severe hemodynamic compromise, and multiple systemic comorbidities. Historically, these patients were often deemed "inoperable" or "un-treatab

Review Paper | 2026 | Volume 2 | Issue 1 | Page 67 - 72 Dr. SK Singh, Assistant Professor, Department of Cardiology, BSMCH, Bangladesh Abstract The management of structural heart disease (SHD) has undergone a seismic shift, moving from highly invasive surgical repairs to sophisticated, catheter-based interventions. While Transcatheter Aortic Valve Replacement (TAVR) served as the proof-of-concept for this revolution, recent innovations have extended these "NextGen" therapies

Review Paper | 2026 | Volume 2 | Issue 1 | Page 57 - 66 Dr. Armenian, Assistant Professor, Department of Cardiology, BSMCH, Bangladesh Abstract Transcatheter Aortic Valve Replacement (TAVR) has emerged as the definitive therapy for symptomatic severe aortic stenosis, fundamentally altering the management of valvular heart disease. Initially reserved for patients deemed "inoperable" or at prohibitive surgical risk, TAVR has expanded its clinical footprint through a series of l

Review Paper | 2026 | Volume 2 | Issue 1 | Page 49 - 56 Dr. Armenian, Assistant Professor, Department of Cardiology, BSMCH, Bangladesh Abstract The integration of robotics into the cardiac catheterization laboratory marks a transformative shift from man ual, tactile-based procedures to computer-assisted, precision-guided interventions. Traditionally, Percutaneous Coronary Intervention (PCI) has relied on the manual manipulation of catheters, guidewires, and stents, which—whil

Review Paper | 2026 | Volume 2 | Issue 1 | Page 41- 48 1. Dr. M. Ganga, Associate Professor, Department of Cardiology, J. J. Institute of Med. Sci. UAE 2. Dr. Abrahim Ghosh, Professor, Department of Cardiology, M.S. Ramahia M. C. India (Corresponding Author) Abstract The evolution of percutaneous coronary intervention (PCI) has been defined by the continuous quest to overcome the biological limitations of the vascular wall. While the transition from Bare-Metal Stents (BMS) t

Review Paper | 2026 | Volume 2 | Issue 1 | Page 34-40 1) Dr. Sami Khatoon, Assistant Professor, Department of Cardiology, AEHIMS-UAE 2) Dr. Asli Jana Parveen, Assistant Professor, Department of General Surgery, DMC-UAE (Corresponding Author) Abstract The landscape of interventional cardiology is undergoing a profound transformation, moving away from the limitations of two-dimensional luminography toward high-resolution, multi-modal intravascular and extra-cardiac imaging. W